MODULAR MEDICAL, INC.: 10-Q filed 2018-02-14

Name: MODULAR MEDICAL, INC.: 10-Q filed 2018-02-14
Creator: MODULAR MEDICAL, INC.

What MODULAR MEDICAL, INC. reported in its quarterly report filed 2018-02-14 (fiscal Q3 2018): 30 published measures, 82 facts as tagged in accession 0001019056-18-000341.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-02-14
Fiscal period: fiscal Q3 2018
Accession: 0001019056-18-000341 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MODULAR MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-12-31	4,532,965	USD
At 2017-03-31	392,313	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-12-31	32,601	USD
At 2017-03-31	29,681	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-12-31	4,500,364	USD
At 2017-03-31	362,632	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-12-31	4,510,052	USD
At 2017-03-31	392,007	USD
At 2016-12-31	1,465	USD
At 2016-03-31	389,623	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	-258,772	USD	92
2017-04-01 to 2017-12-31	-477,863	USD	275
2016-10-01 to 2016-12-31	-6,427	USD	92
2016-04-01 to 2016-12-31	-7,568	USD	275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-04-01 to 2017-12-31	-544,837	USD	275
2016-04-01 to 2016-12-31	-7,874	USD	275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2017-04-01 to 2017-12-31	13,032	USD	275
2016-04-01 to 2016-12-31	0	USD	275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2017-10-01 to 2017-12-31	USD	92
2017-04-01 to 2017-12-31	USD	275
2016-10-01 to 2016-12-31	USD	92
2016-04-01 to 2016-12-31	USD	275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-04-01 to 2017-12-31	-21,256	USD	275
2016-04-01 to 2016-12-31	-380,284	USD	275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2017-04-01 to 2017-12-31	4,684,138	USD	275
2016-04-01 to 2016-12-31	0	USD	275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-12-31	-553,013	USD
At 2017-03-31	-75,150	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	15,983,273	shares	92
2017-04-01 to 2017-12-31	12,895,670	shares	275
2016-10-01 to 2016-12-31	7,582,060	shares	92
2016-04-01 to 2016-12-31	7,582,060	shares	275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	15,983,273	shares	92
2017-04-01 to 2017-12-31	12,895,670	shares	275
2016-10-01 to 2016-12-31	7,582,060	shares	92
2016-04-01 to 2016-12-31	7,582,060	shares	275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	800	USD	92
2017-04-01 to 2017-12-31	800	USD	275
2016-10-01 to 2016-12-31	800	USD	92
2016-04-01 to 2016-12-31	800	USD	275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-12-31	12,274	USD
At 2017-03-31	0	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	-260,860	USD	92
2017-04-01 to 2017-12-31	-480,971	USD	275
2016-10-01 to 2016-12-31	-5,812	USD	92
2016-04-01 to 2016-12-31	-7,567	USD	275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-12-31	4,512,961	USD
At 2017-03-31	392,313	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2017-04-01 to 2017-12-31	0	USD	275
2016-04-01 to 2016-12-31	187,951	USD	275

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	260,860	USD	92
2017-04-01 to 2017-12-31	480,971	USD	275
2016-10-01 to 2016-12-31	5,812	USD	92
2016-04-01 to 2016-12-31	7,567	USD	275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	171,045	USD	92
2017-04-01 to 2017-12-31	258,799	USD	275
2016-10-01 to 2016-12-31	0	USD	92
2016-04-01 to 2016-12-31	0	USD	275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-12-31	15,983,273	shares
At 2017-03-31	7,582,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-12-31	5,037,394	USD
At 2017-03-31	430,200	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2017-12-31	13,032	USD
At 2017-03-31	0	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2017-12-31	758	USD
At 2017-03-31	0	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2017-12-31	230	USD
At 2017-03-31	0	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2017-12-31	0	USD
At 2017-03-31	0	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	-257,972	USD	92
2017-04-01 to 2017-12-31	-477,063	USD	275
2016-10-01 to 2016-12-31	-5,627	USD	92
2016-04-01 to 2016-12-31	-6,768	USD	275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-10-01 to 2017-12-31	44,769	USD	92
2017-04-01 to 2017-12-31	63,897	USD	275
2016-10-01 to 2016-12-31	17	USD	92
2016-04-01 to 2016-12-31	62	USD	275

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2017-04-01 to 2017-12-31	0	USD	275
2016-04-01 to 2016-12-31	0	USD	275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-04-01 to 2017-12-31	0	USD	275
2016-04-01 to 2016-12-31	306	USD	275

Inspect the source

Entity: MODULAR MEDICAL, INC. / CIK 0001074871
Captured: 2026-09-20T05:20:05.018Z
SEC response SHA-256: 35d9c7a349fec6383baca56e8aa4820d6d19d2f4955371898b75285f3bf308e4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001074871.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))